Hua Wei, Ying Cui, Yang Chen, Shijie Mu. The progress of abnormal expression of Lutheran blood group glycoprotein in cancers[J]. Blood&Genomics, 2020, 4(1): 39-44. DOI: 10.46701/BG2020012020105
Citation: Hua Wei, Ying Cui, Yang Chen, Shijie Mu. The progress of abnormal expression of Lutheran blood group glycoprotein in cancers[J]. Blood&Genomics, 2020, 4(1): 39-44. DOI: 10.46701/BG2020012020105

The progress of abnormal expression of Lutheran blood group glycoprotein in cancers

  • Lutheran blood group glycoprotein (Lu-gp) is a specific α5 laminin receptor that is linked by binding to its receptor in the basement membrane matrix. Although the biological function of Lu-gp is unknown, its special affinity with laminin in the chain suggests that it plays an important role in human development and physiological processes. As the interaction between Lu-gp and laminin is further investigated, their expression may be found to play an important role in tumor invasion and metastasis. Laminin receptors help cells adhere, receive and conduct extracellular information into cells, mainly through MAPK pathways, including ERKs, p38MAPK, etc., affecting the degradation of the extracellular matrix and enhancing tumor cell infiltration and metastasis. Present researches in cancers mainly focus on aspects relating to laminin, but largely do not pay attention to the Lutheran blood group antigen, basal cell adhesion molecule. This paper focuses on the abnormal expression of the laminin receptor, that is, the Lutheran blood group antigen, in cancers, which is of great significance to the mechanism of cancer invasion and metastasis, and for finding effective treatment methods for cancers.
  • loading

Catalog

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return